- Cell-specific targeting of extracellular vesicles though engineeringthe glycocalyx
Zheng, et al.
Journal of Extracellular Vesiclesdoi: https://doi.org/10.1002/jev2.12290
- A Bayesian implementation of Quality-by-Design for the development of Cationic Nano-Lipid for siRNA Transfection
Bastogne, Thierry, et al.
IEEE Transactions on NanoBiosciencedoi: https://doi.org/10.1109/tnb.2022.3213412
- Principles for designing an optimal mRNA lipid nanoparticle vaccine
Kon, Edo, et al.
Current Opinion in Biotechnologydoi: https://doi.org/10.1016/j.copbio.2021.09.016
- Delivery strategies of RNA therapeutics to leukocytes
Tarab-Ravski, Dana, et al.
Journal of Controlled Releasedoi: https://doi.org/10.1016/j.jconrel.2022.01.016
- Nanotechnology-based strategies against SARS-CoV-2 variants
Huang, Xiangang, et al.
Nature Nanotechnologydoi: https://doi.org/10.1038/s41565-022-01174-5
- mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
Bevers, Sanne, et al.
Molecular Therapydoi: https://doi.org/10.1016/j.ymthe.2022.07.007
- A state of the art in analytical quality-by-design and perspectives in characterization of nano-enabled medicinal products
Bastogne, Thierry, et al.
Journal of Pharmaceutical and Biomedical Analysisdoi: https://doi.org/10.1016/j.jpba.2022.114911
- Identification of storage conditions stabilizing extracellular vesicles preparations
Görgens, André, et al.
Journal of Extracellular Vesiclesdoi: https://doi.org/10.1002/jev2.12238
- Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics
Vervaeke, Pieter, et al.
Advanced Drug Delivery Reviewsdoi: https://doi.org/10.1016/j.addr.2022.114236
- Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles
Evers, Martijn J.W., et al.
Journal of Controlled Releasedoi: https://doi.org/10.1016/j.jconrel.2022.01.027
- Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines
Szebeni, J., et al.
Nature Nanotechnologydoi: https://doi.org/10.1038/s41565-022-01071-x
- Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement
Estapé Senti, Mariona, et al.
Journal of Controlled Releasedoi: https://doi.org/10.1016/j.jconrel.2021.11.042
- A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor
Dézsi, L., et al.
GeroSciencedoi: https://doi.org/10.1007/s11357-021-00495-y